Home
CTKB
CTKB News

Latest Cytek Biosciences Inc. (CTKB) News on May 16, 2025

Argus Research

2 days ago

CTKB: Lowering target price to $2.00

Cytek Biosciences First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

6 days ago

Cytek Biosciences First Quarter 2025 Earnings: Misses Expectations

MT Newswires

7 days ago

TD Cowen Downgrades Cytek Biosciences to Hold From Buy, Adjusts Price Target to $4 From $7

GuruFocus.com

7 days ago

Cytek Biosciences Inc (CTKB) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Market ...

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates

Zacks

7 days ago

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates

Cytek Biosciences Reports First Quarter 2025 Financial Results

GlobeNewswire

7 days ago

Cytek Biosciences Reports First Quarter 2025 Financial Results

What To Expect From Cytek Biosciences Inc (CTKB) Q1 2025 Earnings

GuruFocus.com

9 days ago

What To Expect From Cytek Biosciences Inc (CTKB) Q1 2025 Earnings

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

GlobeNewswire

16 days ago

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire

21 days ago

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Argus Research

23 days ago

CTKB: What does Argus have to say about CTKB?

April 2025's Top Penny Stocks To Watch

Simply Wall St.

a month ago

April 2025's Top Penny Stocks To Watch

Argus Research

a month ago

CTKB: What does Argus have to say about CTKB?

Argus Research

a month ago

CTKB: What does Argus have to say about CTKB?

Argus Research

a month ago

CTKB: What does Argus have to say about CTKB?

Argus Research

2 months ago

CTKB: What does Argus have to say about CTKB?

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

GlobeNewswire

2 months ago

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Open Lending Leads Our Trio Of Promising Penny Stocks

Simply Wall St.

2 months ago

Open Lending Leads Our Trio Of Promising Penny Stocks

Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock?

Insider Monkey

2 months ago

Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock?

Argus Research

2 months ago

CTKB: Lowering target price to $3.00

Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation?

Simply Wall St.

3 months ago

Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation?

GuruFocus.com

3 months ago

Cytek Biosciences Inc (CTKB) Q4 2024 Earnings Call Highlights: Strong International Growth and ...

Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates

Zacks

3 months ago

Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

GlobeNewswire

3 months ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

GuruFocus.com

3 months ago

Earnings To Watch: Cytek Biosciences Inc (CTKB) Reports Q4 2024 Result

Argus Research

3 months ago

CTKB: What does Argus have to say about CTKB?

Argus Research

3 months ago

CTKB: What does Argus have to say about CTKB?

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

GlobeNewswire

3 months ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Cytek Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

3 months ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Argus Research

3 months ago

CTKB: Lowering target price to $4.00

MT Newswires

4 months ago

Goldman Sachs Downgrades Cytek Biosciences to Sell From Buy, Adjusts Price Target to $4.50 From $7

Argus Research

4 months ago

CTKB: What does Argus have to say about CTKB?

Cytek Biosciences, Inc. (NASDAQ:CTKB) is largely controlled by institutional shareholders who own 53% of the company

Simply Wall St.

4 months ago

Cytek Biosciences, Inc. (NASDAQ:CTKB) is largely controlled by institutional shareholders who own 53% of the company

Argus Research

4 months ago

CTKB: Lowering target price to $5.00

Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results

GlobeNewswire

4 months ago

Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results

Argus Research

4 months ago

CTKB: Raising target price to $7.00

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

4 months ago

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

5 months ago

Cytek Biosciences Launches $50 Million Share Buyback

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

GlobeNewswire

5 months ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Argus Research

5 months ago

CTKB: What does Argus have to say about CTKB?

Argus Research

5 months ago

CTKB: What does Argus have to say about CTKB?

Argus Research

5 months ago

CTKB: What does Argus have to say about CTKB?

Argus Research

5 months ago

CTKB: What does Argus have to say about CTKB?

Argus Research

6 months ago

CTKB: What does Argus have to say about CTKB?

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire

6 months ago

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

GlobeNewswire

6 months ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Argus Research

6 months ago

CTKB: Raising target price to $6.00

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

GlobeNewswire

6 months ago

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

6 months ago

Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ...

Argus Research

6 months ago

CTKB: What does Argus have to say about CTKB?

Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat Estimates

Zacks

6 months ago

Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat Estimates

Cytek Biosciences Reports Third Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Cytek Biosciences Reports Third Quarter 2024 Financial Results

What To Expect From Cytek Biosciences Inc (CTKB) Q3 2024 Earnings

GuruFocus.com

6 months ago

What To Expect From Cytek Biosciences Inc (CTKB) Q3 2024 Earnings

November 2024's Top US Penny Stocks With Growth Potential

Simply Wall St.

6 months ago

November 2024's Top US Penny Stocks With Growth Potential

Cytek Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

7 months ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

GlobeNewswire

7 months ago

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

Argus Research

7 months ago

CTKB: What does Argus have to say about CTKB?

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

GlobeNewswire

8 months ago

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Intrinsic Value Is Potentially 99% Above Its Share Price

Simply Wall St.

8 months ago

Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Intrinsic Value Is Potentially 99% Above Its Share Price

MT Newswires

8 months ago

Cytek Biosciences COO Chris Williams Resigns

Cytek Announces Resignation of Chief Operating Officer Chris Williams

GlobeNewswire

8 months ago

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Argus Research

9 months ago

CTKB: What does Argus have to say about CTKB?

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

GlobeNewswire

9 months ago

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Argus Research

9 months ago

CTKB: What does Argus have to say about CTKB?

Cytek Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

9 months ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

9 months ago

Cytek Biosciences Second Quarter 2024 Earnings: Misses Expectations

Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue Estimates

Zacks

9 months ago

Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue Estimates

Cytek Biosciences Reports Second Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Cytek Biosciences Reports Second Quarter 2024 Financial Results

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

GlobeNewswire

10 months ago

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

GlobeNewswire

10 months ago

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

Argus Research

10 months ago

CTKB: What does Argus have to say about CTKB?

Cytek Biosciences, Inc. (NASDAQ:CTKB) is a favorite amongst institutional investors who own 51%

Simply Wall St.

10 months ago

Cytek Biosciences, Inc. (NASDAQ:CTKB) is a favorite amongst institutional investors who own 51%

Argus Research

10 months ago

CTKB: What does Argus have to say about CTKB?

Argus Research

10 months ago

CTKB: Raising target price to $5.00

Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?

Zacks

a year ago

Cytek Biosciences (CTKB) Moves 5.1% Higher: Will This Strength Last?

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow

AFP

a year ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Investor's Business Daily

a year ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

The Wall Street Journal

a year ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

MT Newswires

a year ago

Cytek Biosciences Board Approves $50 Million Share Buyback Plan

Cytek Biosciences Announces $50 Million Stock Repurchase Program

GlobeNewswire

a year ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

a year ago

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

MT Newswires

a year ago

Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

GlobeNewswire

a year ago

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

GlobeNewswire

a year ago

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

MT Newswires

a year ago

Piper Sandler Adjusts Price Target on Cytek Biosciences to $8.50 From $10, Maintains Overweight Rating

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript

Cytek Biosciences Inc (CTKB) Q1 2024 Earnings: Revenue Surges, Yet Net Loss Persists

GuruFocus.com

a year ago

Cytek Biosciences Inc (CTKB) Q1 2024 Earnings: Revenue Surges, Yet Net Loss Persists

GuruFocus.com

a year ago

Cytek Biosciences Inc (CTKB) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates

Zacks

a year ago

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates

Cytek Biosciences Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Cytek Biosciences Reports First Quarter 2024 Financial Results

Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know

Zacks

a year ago

Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

GlobeNewswire

a year ago

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

GlobeNewswire

a year ago

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True?

Zacks

a year ago

Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True?

Argus Research

a year ago

CTKB: What does Argus have to say about CTKB?

Share on Social Networks: